ERGOMED has announced the establishment of its Rare Disease Innovation Center™.
The Rare Disease Innovation Center™ is a consortium of innovative partners and internal subject matter experts dedicated to developing tailored solutions for rare disease-focused companies and patients.
In addition, ERGOMED has announced new partnerships with Trialbee and mdgroup as part of its new consortium. Trialbee will serve as its patient identification partner and mdgroup will provide patient support servces.
Read more about this announcement by following the links below:
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.